LogicBio Therapeutics Inc. (LOGC)
$12.76
$6.08
(91.02%)
As on 28-Aug-2026 10:32EDT
Market cap
$519 Mln
Revenue (TTM)
$32 Mln
P/E Ratio
--
P/B Ratio
1.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
1
-
Debt to Equity
--
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
45,753,716
8 Years Aggregate
CFO
$-1,805.09 Mln
EBITDA
$-1,648.80 Mln
Net Profit
$-1,873.97 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
LogicBio Therapeutics (LOGC)
| -- | -- | -- | -- | -- | 22.2 | -- |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2021
|
2020
|
2019
|
|---|---|---|---|
|
LogicBio Therapeutics (LOGC)
| -69.7 | 6.0 | -30.8 |
|
S&P Small-Cap 600
| 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
LogicBio Therapeutics (LOGC)
|
12.8 | 518.9 | 0.0 | -29.0 | 0.0 | -20.4 | -- | 1.8 |
| 13.9 | 914.4 | 0.0 | -175.9 | -- | -106.8 | -- | 5.6 | |
| 12.5 | 2,195.3 | 549.1 | 17.9 | -6.3 | 1.4 | 126.3 | 1.7 | |
| 4.7 | 1,105.5 | 4.5 | -340.2 | -518.6 | 501.4 | -- | 2.1 | |
| 17.8 | 2,204.8 | 65.4 | -94.4 | -108.2 | -16.1 | -- | 3.9 | |
| 11.7 | 838.7 | 366.5 | 9.3 | 8.3 | 3.4 | 84.6 | 3.1 | |
| 3.5 | 614.9 | 4.1 | -187.9 | -4,613.1 | -233.9 | -- | 0.3 | |
| 17.4 | 424.0 | 4.7 | -109.7 | -- | -30.2 | -- | 1.2 | |
| 13.5 | 824.8 | 0.6 | -59.9 | -9,892.6 | -118.9 | -- | 21.3 | |
| 26.0 | 2,920.0 | 449.6 | -188.2 | -41.1 | -28.5 | -- | 4.8 |
Shareholding Pattern
View DetailsAbout LogicBio Therapeutics (LOGC)
ContextLogic Holdings Inc. focuses on seeking to develop and grow a de novo business and finance potential future bolt-on acquisitions of assets or businesses. The company was incorporated in 2010 and is headquartered in Oakland, California.
-
Pres, CEO & Director
Mr. Frederic Chereau M.B.A.
-
Pres, CEO & Director
Mr. Frederic Chereau M.B.A.
-
Headquarters
Oakland, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for LogicBio Therapeutics (LOGC)
What is the current share price of LogicBio Therapeutics Inc (LOGC) Today?
The share price of LogicBio Therapeutics Inc (LOGC) is $12.76 (NASDAQ) as of 28-Aug-2026 10:32 EDT. LogicBio Therapeutics Inc (LOGC) has given a return of --% in the last 1 years.
What is the current PB & PE ratio of LogicBio Therapeutics Inc (LOGC)?
Since, TTM earnings of LogicBio Therapeutics Inc (LOGC) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-- |
-- |
2024 |
-2.46 |
1.22 |
2023 |
-- |
-- |
2022 |
-- |
-- |
2021 |
-0.21 |
0.09 |
What is the 52 Week High and Low of LogicBio Therapeutics Inc (LOGC)?
The 52-week high and low of LogicBio Therapeutics Inc (LOGC) are Rs 13.25 and Rs 12.70 as of 28-Aug-2026.
What is the market cap of LogicBio Therapeutics Inc (LOGC)?
LogicBio Therapeutics Inc (LOGC) has a market capitalisation of $ 519 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in LogicBio Therapeutics Inc (LOGC)?
Before investing in LogicBio Therapeutics Inc (LOGC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.